ESG regulations in Healthcare & Pharmaceutical sector

Policymakers are taking a tougher stance on ESG regulations in Healthcare & Pharmaceutical sector.

Right click to download

Policymakers are taking a tougher stance on ESG regulations in Healthcare & Pharmaceutical sector: more mandatory regulations have been introduced in the last three years compared to the previous period.

Global Insights Report: The rise of ESG regulations

The evolution of accountability shows us it is only a matter of time before prominent voluntary initiatives will become mandatory regulations, as such being ahead of the curve will help businesses mitigate any backlash.

How can companies navigate the complexity of the constantly evolving ESG regulatory landscape? What voluntary initiatives are worth a consideration? What material non-financial topics are emerging and developing? Finally, with policymakers being the key stakeholder group for business, the report helps to analyze and identify their activities as well as potential impacts on business.

Download your Global Insights Report to stay on top of your ESG risks.

Global Insights Report 2018 - the rise of ESG regulations

Sign up here to receive our newsletter.